IVC Evidensia appoints Gudrun Ravetz as Group Chief Medical Officer
Monday, October 2, 2023
IVC Evidensia is delighted to announce that Gudrun Ravetz will be joining as Group Chief Medical Officer (CMO) in February 2024.
Graduating as a vet in 2002, Gudrun worked in a variety of practice types and has had a progressive career encompassing significant roles across the industry, gaining a broad range of experience and having helped to shape the veterinary landscape.
Gudrun will join IVC Evidensia having worked her notice from her current role of Group Veterinary Officer at Pets at Home, where she has responsibility for veterinary and retail operations. Gudrun was previously Head of Workplace Engagement at Vets4Pets, following a portfolio career including 14 years as Head Veterinary Officer at pet health plan business SimplyHealth.
Gudrun's dedication to advancing the veterinary profession is reflected by her long-standing involvement with the British Veterinary Association (BVA), including as President, where she represented the profession's interests to parliament, media, and international bodies, and chaired the Good Veterinary Workplaces working group. She has been a member of multiple working groups at the Royal College of Veterinary Surgeons, is currently a non-executive director at the Veterinary Defence Society, and is a Director and previous Chair at Vet Sustain, which supports vet-led teams and veterinary professionals to be a leading force for sustainability.
As Group CMO, Gudrun will report directly to CEO Simon Smith, and work closely with our country CMOs and practice teams to deliver, and continue to develop, the clinical vision and strategy for IVC Evidensia. She will help ensure our practices and hospitals across the world are best placed to deliver on our purpose of Healthy Animals, Happy Owners through the provision of high-quality care for animals, service to customers, and support for our people.
Simon Smith, CEO, said: “Gudrun's extensive veterinary expertise, and commitment to progress in our rapidly changing profession, will be invaluable in ensuring our clinical vision supports ever-better animal health outcomes, an outstanding customer experience, and the development of our practice teams. I know she’ll make a considerable contribution to the continued evolution and growth of our business and am delighted to welcome her to the team. I would like to thank Amanda for her considerable contributions to IVC Evidensia, including developing our network of Country Medical Directors, supporting our clinics in delivering outstanding levels of care, and furthering the interests of our business and our industry.”
Gudrun Ravetz, incoming CMO, said: “I’m looking forward to contributing to the positive and significant difference that IVC Evidensia makes to the quality of life for over 8 million animals and their owners worldwide every year. The focus will be on helping ensure the dedicated and highly qualified veterinary teams across IVC Evidensia have the support, training and clinical guidance they need to navigate the fast-changing landscape of our vital profession, while continuing to deliver the outstanding care and customer service for which they are renowned.”
Gudrun takes over from Amanda Boag, who is fulfilling her desire to return to academia, having accepted a significant position at the Royal Veterinary College (RVC). Amanda will leave IVC Evidensia in November.